These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 4588854)
1. Treatment of obesity with fenfluramine. Persson I; Andersen U; Deckert T Eur J Clin Pharmacol; 1973 Aug; 6(2):93-7. PubMed ID: 4588854 [No Abstract] [Full Text] [Related]
2. [Treatment of obesity with fenfluramine (Ponderal)]. Persson I; Andersen UD; Deckert T Ugeskr Laeger; 1973 Sep; 135(36):1932-7. PubMed ID: 4590075 [No Abstract] [Full Text] [Related]
3. Fenfluramine in corticosteroid-induced obesity. Cameron DC; Kennedy WP; Samuel PD; Crompton GK Curr Med Res Opin; 1972; 1(3):153-8. PubMed ID: 4589709 [No Abstract] [Full Text] [Related]
4. Circulatory effects of fenfluramine in obese hypertensive patients. Mroczek WJ; Lee WR; Finnerty FA Curr Ther Res Clin Exp; 1974 Nov; 16(11):1197-202. PubMed ID: 4214654 [No Abstract] [Full Text] [Related]
5. [The therapeutic effect of Fenfluramine on body weight in overweight patients. A controlled clinical study]. Haug E; Myklebust R Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2545-9. PubMed ID: 4589598 [No Abstract] [Full Text] [Related]
6. Treatment of obesity with fenfluramine. Schindler H; Bielesz G Wien Med Wochenschr; 1975 Jan; 125(5):85-8. PubMed ID: 1124579 [No Abstract] [Full Text] [Related]
7. Anorectic effectiveness of differing dosage forms of fenfluramine. Tisdale SA; Ervin DK Curr Ther Res Clin Exp; 1976 Jun; 19(6):589-94. PubMed ID: 819218 [No Abstract] [Full Text] [Related]
9. Fenfluramine in the treatment of obesity. Stunkard A; Rickels K; Hesbacher P Lancet; 1973 Mar; 1(7802):503-5. PubMed ID: 4119946 [No Abstract] [Full Text] [Related]
10. A controlled investigation of the "glycolyptic" action of fenfluramine. Garrow JS; Belton EA; Daniels A Lancet; 1972 Sep; 2(7777):559-61. PubMed ID: 4115737 [No Abstract] [Full Text] [Related]
11. A trial of fenfluramine in children with obesity associated with reduced muscle activity. Court JM S Afr Med J; 1972 Feb; 46(6):132-3. PubMed ID: 4552171 [No Abstract] [Full Text] [Related]
12. Fenfluramine in obese patients on various antihypertensive drugs. Double-blind controlled trial. Waal-Manning HJ; Simpson FO Lancet; 1969 Dec; 2(7635):1392-5. PubMed ID: 4188278 [No Abstract] [Full Text] [Related]
13. [Glucose tolerance, insulin and lipids after one week's administration of fenfluramine to overweight patients (author's transl)]. Weisweiler P; Schwandt P MMW Munch Med Wochenschr; 1975 Nov; 117(48):1925-8. PubMed ID: 813120 [TBL] [Abstract][Full Text] [Related]
14. Effects of prolonged fenfluramine administration in obese and nonobese mice. Carr RH; Ipaktchi M; Thenen SW Proc Soc Exp Biol Med; 1977 Jan; 154(1):116-20. PubMed ID: 320596 [No Abstract] [Full Text] [Related]
15. A collaborative investigation of fenfluramine. Anorexigenic with sedative properties. Elliott BW Curr Ther Res Clin Exp; 1970 Aug; 12(8):502-15. PubMed ID: 4988837 [No Abstract] [Full Text] [Related]
16. [The effect of Ponderal in patients with refractory overweight]. Myking O; Bassoe HH; Closs K Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2541-5. PubMed ID: 4589597 [No Abstract] [Full Text] [Related]